Director/PDMR Shareholding

Summary by AI BETAClose X

Centrica plc announced that Non-Executive Directors Philippe Boisseau and Sue Whalley acquired ordinary shares on November 25, 2025, under their respective Share Purchase Agreements. Philippe Boisseau acquired 1,080 shares at £1.626030 per share, totaling £1,756.11, while Sue Whalley purchased 600 shares at the same price, amounting to £975.62. These transactions, executed on the London Stock Exchange, represent an initial notification of director share acquisitions.

Disclaimer*

Centrica PLC
25 November 2025
 

Centrica plc (the 'Company')

25 November 2025

Notification of Transactions of Directors

The Company was notified by Equiniti Financial Services Limited, that Directors acquired Centrica plc ordinary shares of 6 14/81 pence ('Shares') in accordance with their Share Purchase Agreements held with the Company.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Philippe Boisseau

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 14/81 pence (Shares)

 

 

GB00B033F229

b)

Nature of the transaction

Acquisition of Shares in accordance with the Share Purchase Agreement entered into with the Company on 5 March 2025.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.626030

1,080

d)

Aggregated information

Total

 

£1,756.11

e)

Date of the transaction

25 November 2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Sue Whalley

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 14/81 pence (Shares)

 

 

GB00B033F229

b)

Nature of the transaction

Acquisition of Shares in accordance with the Share Purchase Agreement entered into with the Company on 8 September 2025.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.626030

600

d)

Aggregated information

Total

 

£975.62

e)

Date of the transaction

25 November 2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Centrica (CNA)
UK 100

Latest directors dealings